News

Filter

Current filters:

Zaltrapaflibercept

Sanofi-Aventis and Regeneron’s Zaltrap improves OS in Ph III colon cancer study

28-04-2011

French drug major Sanofi-Aventis (Euronext: SAN) and USA-based partner Regeneron Pharmaceuticals (Nasdaq:…

afliberceptOncologyPharmaceuticalRegeneronResearchSanofi-AventisZaltrap

COMPANY SPOTLIGHT

Menarini

Back to top